Covivio S.A (COV) | Stock Overview & Key Data

Covivio S.A. | Large-cap | Healthcare

€51.10

0.10%

| Covivio S.A Stock Comparison:

Covivio S.A vs Compagnie du Covivio S.A vs Pluxee NV Covivio S.A vs Carmila S.A Covivio S.A vs Medincell S.A Covivio S.A vs Valneva SE Covivio S.A vs CAC 40 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Covivio S.A Performance Comparison

Loading chart data...

Covivio S.A

CAC 40

View Full Price History

Stock Range

Today's Range

Low: €50.80 High: €51.25

on June 17, 2025

52 Week Range

Low: €43.40 High: €56.85

on April 9, 2025

on October 16, 2024

All-Time High: €112.20 on February 17, 2020

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €5.7B

EPS i 0.63

P/E Ratio (TTM) i 81.03

Forward P/E i 11.71

P/B Ratio i 0.69

PEG Ratio i 11.71

Div. Yield i 6.86%

ROE i 1.65%

Beta i 1.374

Debt to Equity i 90.76

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 94.12%

Profit Margin i 6.09%

Returns and Earnings

Return on Assets (TTM) i 2.40%

Return on Equity (TTM) i 1.65%

EBITDA i €1.7B

Net Income (TTM) i €68.1M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i N/A

Dividend Information

Expected Yearly Dividend i €14.00

Estimated Dividend Yield i 27.42%

5 Year Average Dividend Yield i 6.73%

Last 12-Month Dividend Yield i 6.86%

Last 12-Month Dividend i €3.50

% of Earnings Paid as Dividends i 523.81%

Dividend Date i N/A

Ex-Dividend Date i April 30, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Covivio S.A COV	5.71B Large-cap	-0.97%	1.19%	-0.39%	4.93%	3.02%	14.00%	-9.89%	-24.98%
Compagnie du CBDG	6.31B Large-cap	-0.99%	1.01%	-18.70%	-2.44%	-13.79%	51.82%	90.83%	112.24%
Pluxee NV PLX	2.87B Large-cap	-6.00%	-7.40%	-15.42%	-1.22%	0.38%	-26.94%	-35.10%	-35.10%
Carmila S.A CARM	2.35B Large-cap	1.18%	-10.01%	-3.28%	8.51%	5.56%	4.12%	15.99%	27.52%
Medincell S.A MEDCL	516.86M Mid-cap	-3.19%	1.18%	11.44%	-5.78%	-11.69%	10.83%	183.49%	78.41%
Valneva SE VLA	462.57M Mid-cap	-3.75%	-10.45%	-19.94%	46.02%	11.26%	-20.12%	-67.00%	-34.99%

Ownership & Short Interest

Insider Ownership i 35.82%

Institutional Ownership i 41.59%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 84K

Average 90-Day Volume i 117K

Covivio S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Covivio S.A would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is COV's 52-week high and low?

In the last 52 weeks, Covivio S.A reached a high of €56.85 (on October 16, 2024) and a low of €43.40 (on April 9, 2025).

What is the market cap and P/E ratio for COV?

Curious about Covivio S.A's size and valuation? Its market capitalization stands at 5.71B. When it comes to valuation, the P/E ratio (trailing twelve months) is 81.03, and the forward P/E (looking ahead) is 11.71.

Does COV pay dividends? If so, what's the yield?

Yes, Covivio S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 6.86%, and the company is expected to pay out €14.00 per share over the coming year.

Who are Covivio S.A's main competitors or similar companies to consider before investing?

When looking at Covivio S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Compagnie du CBDG	6.31B	Healthcare	Biotechnology	51.82%	90.83%
Pluxee NV PLX	2.87B	Healthcare	Biotechnology	-26.94%	-35.10%
Carmila S.A CARM	2.35B	Healthcare	Biotechnology	4.12%	15.99%
Medincell S.A MEDCL	516.86M	Healthcare	Biotechnology	10.83%	183.49%
Valneva SE VLA	462.57M	Healthcare	Biotechnology	-20.12%	-67.00%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Covivio S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Covivio S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.65%, the Debt to Equity ratio from the most recent quarter is 90.76, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for COV?

Looking at Covivio S.A's growth, its revenue over the trailing twelve months (TTM) was €1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.00%, and quarterly earnings saw a YoY growth of N/A.

How much of COV stock is held by insiders and institutions?

Wondering who owns Covivio S.A stock? Company insiders (like executives and directors) hold about 35.82% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 41.59%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.